BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Macquarie maintains outperform on Fortis Healthcare
Macquarie maintains 'outperform' on Fortis Healthcare and has increased its target price to Rs 260/share. It says Fortis is currently trading at 13.4 times FY17 estimated enterprise value/EBITDA and is well positioned to capitalize significant opportunity. Macquarie has changed EBITDA estimates for FY17-18 to Rs 640-860 crore.